Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices

被引:24
作者
Malhotra, Rajiv [1 ]
Shah, Keyur B. [2 ]
Chawla, Raveen [3 ]
Pedram, Samy [1 ]
Smalfield, Melisa C. [2 ]
Priday, Anna G. [4 ]
DeWilde, Christine T. [4 ]
Brophy, Donald F. [5 ]
机构
[1] VCU, Div Pulm & Crit Care Med, Richmond, VA USA
[2] VCU, Pauley Heart Ctr, Div Cardiol, Richmond, VA USA
[3] VCU, Dept Internal Med, Richmond, VA USA
[4] VCU, Johnson Ctr Crit Care & Pulm Res, Richmond, VA USA
[5] VCU, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA USA
关键词
cardiomyopathy; left ventricular assist device; octreotide; VON-WILLEBRAND SYNDROME; GASTROINTESTINAL HEMORRHAGE; SOMATOSTATIN; INHIBITION; OUTCOMES;
D O I
10.1097/MAT.0000000000000491
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Patients with implanted continuous, nonpulsatile, left ventricular assist devices (LVADs) have increased the occurrence of gastrointestinal bleeding (GIB). Although the pathophysiology is multifactorial, there are few treatments beyond supportive care. Octreotide acetate is a somatostatin analog that reduces GIB in various patient populations. However, there are sparse case series that suggest octreotide acetate may reduce GIB in LVAD patients. This 10 patient, 28 week phase I study evaluated the safety and tolerability of octreotide acetate long-acting release (LAR) 20 mg depot injection every 4 weeks until week 16 after LVAD placement. Secondary aims were occurrence of GIB and measurement of vascular endothelial growth factor, fibrinogen, von Willebrand factor, and platelet aggregation across the study period. Ten patients were enrolled, and eight completed the study. The two study dropouts were not related to octreotide. None of the patients experienced side effects or safety concerns related to octreotide nor did GIB occur in the study population. Vascular endothelial growth factor levels were maintained in the reference range throughout the duration of the study. There did appear to be laboratory evidence of acquired von Willebrand syndrome, with mildly low platelet aggregation studies. In conclusion, octreotide acetate LAR 20 mg depot injection was safe and effective in this population.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 28 条
[1]   Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices [J].
Baghai, Maral ;
Heilmann, Claudia ;
Beyersdorf, Friedhelm ;
Nakamura, Lea ;
Geisen, Ulrich ;
Olschewski, Manfred ;
Zieger, Barbara .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (03) :421-427
[2]   INHIBITION OF ANGIOGENESIS BY SOMATOSTATIN AND SOMATOSTATIN-LIKE COMPOUNDS IS STRUCTURALLY DEPENDENT [J].
BARRIE, R ;
WOLTERING, EA ;
HAJARIZADEH, H ;
MUELLER, C ;
URE, T ;
FLETCHER, WS .
JOURNAL OF SURGICAL RESEARCH, 1993, 55 (04) :446-450
[3]  
Bhutta Abdul Q, 2015, Gastrointest Endosc Clin N Am, V25, P479, DOI 10.1016/j.giec.2015.03.001
[4]   Somatostatin Analogues in the Treatment of Recurrent Bleeding from Gastrointestinal Vascular Malformations: An Overview and Systematic Review of Prospective Observational Studies [J].
Brown, Colin ;
Subramanian, Venkataraman ;
Wilcox, C. Mel ;
Peter, Shajan .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (08) :2129-2134
[5]   Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients [J].
Cascinu, S ;
Del Ferro, E ;
Ligi, M ;
Staccioli, MP ;
Giordani, P ;
Catalano, V ;
Agostinelli, R ;
Muretto, P ;
Catalano, G .
CANCER INVESTIGATION, 2001, 19 (01) :8-12
[6]   Gastrointestinal Bleeding Following Left Ventricular Assist Device (LVAD) Implantation: Taking the Pulse of the Problem [J].
Cassell, Benjamin ;
Kushnir, Vladimir M. .
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (12) :3507-3509
[7]   Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices [J].
Crow, Sheri ;
John, Ranjit ;
Boyle, Andrew ;
Shumway, Sara ;
Liao, Kenneth ;
Colvin-Adams, Monica ;
Toninato, Carol ;
Missov, Emil ;
Pritzker, Marc ;
Martin, Cindy ;
Garry, Daniel ;
Thomas, William ;
Joyce, Lyle .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01) :208-215
[8]   Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom [J].
Cushing, Kelly ;
Kushnir, Vladimir .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (06) :1440-1447
[9]   Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device [J].
Dang, Geetanjali ;
Grayburn, Ryan ;
Lamb, Geoffrey ;
De Reguero, Adrian Umpierrez ;
Gaglianello, Nunzio .
CASE REPORTS IN CARDIOLOGY, 2014, 2014
[10]   GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis [J].
Draper, Karen V. ;
Huang, Robert J. ;
Gerson, Lauren B. .
GASTROINTESTINAL ENDOSCOPY, 2014, 80 (03) :435-U219